Bone Biologics Corp Warrants
$6.05
34
-$1.90-23.9%Monday 19:59
Statistics
Day High
10.67
Day Low
5.39
52W High
35.95
52W Low
3.5
Volume
249
Avg. Volume
928
Mkt Cap
16.67M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-3.24
-2.22
-1.21
-0.19
Expected EPS
-0.19
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-3.11MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Show More
CEO
Jeffrey Frelick
Employees
2
Country
United States
ISIN
US0980701546
Listings
0 Comments
Share your thoughts
FAQs
What is Bone Biologics Corp Warrants stock price today?▼
The current price of BBLGW is $6.05 USD — it has decreased by -23.9% in the past 24 hours. Watch Bone Biologics Corp Warrants stock price performance more closely on the chart.
What is Bone Biologics Corp Warrants stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Bone Biologics Corp Warrants stocks are traded under the ticker BBLGW.
Is Bone Biologics Corp Warrants stock price growing?▼
BBLGW stock has risen by +0% compared to the previous week, the month change is a +51.63% rise, over the last year Bone Biologics Corp Warrants has showed a -41.77% decrease.
What is Bone Biologics Corp Warrants market cap?▼
Today Bone Biologics Corp Warrants has the market capitalization of 16.67M
When is the next Bone Biologics Corp Warrants earnings date?▼
Bone Biologics Corp Warrants is going to release the next earnings report on December 2, 2026.
What were Bone Biologics Corp Warrants earnings last quarter?▼
BBLGW earnings for the last quarter are -0.43 USD per share, whereas the estimation was -0.43 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bone Biologics Corp Warrants revenue for the last year?▼
Bone Biologics Corp Warrants revenue for the last year amounts to 0 USD.
What is Bone Biologics Corp Warrants net income for the last year?▼
BBLGW net income for the last year is -3.11M USD.
How many employees does Bone Biologics Corp Warrants have?▼
As of October 23, 2026, the company has 2 employees.
In which sector is Bone Biologics Corp Warrants located?▼
Bone Biologics Corp Warrants operates in the Health & Wellness sector.
When did Bone Biologics Corp Warrants complete a stock split?▼
The last stock split for Bone Biologics Corp Warrants was on June 10, 2025 with a ratio of 1:6.
Where is Bone Biologics Corp Warrants headquartered?▼
Bone Biologics Corp Warrants is headquartered in BURLINGTON, United States.